981 top medical experts on Myeloproliferative Disorders across 44 countries and 36 U.S. states, including 947 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent myeloid progenitor cells, most often caused by a mutation in the JAK2 protein tyrosine kinase.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Bone Marrow Diseases (741) and Narrower Categories: Acute Erythroblastic Leukemia (715), BCR-ABL Positive Chronic Myelogenous Leukemia (2,669), Chronic Neutrophilic Leukemia (133), Leukemoid Reaction (390), Myelophthisic Anemia (44), Polycythemia Vera (764), Primary Myelofibrosis (1,384), Thrombocytosis (196).
  4. Clinical Trials ClinicalTrials.gov : at least 454 including 32 Active, 258 Completed, 69 Recruiting


  

        

                    


    Computing Expert Listing ...

);